HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Split high-dose oral levothyroxine treatment as a successful therapy option in myxedema coma.

Abstract
High-dose intravenous thyroxine (T4) is the preferable treatment for myxedema coma. We describe the clinical course of a 69-year-old man who presented with myxedema coma and received oral levothyroxine (LT4) therapy (1 mg) in a split dose. This suggests split high-dose oral LT4 as a therapeutic option in myxedema coma.
AuthorsSuranut Charoensri, Chutintorn Sriphrapradang, Hataikarn Nimitphong
JournalClinical case reports (Clin Case Rep) Vol. 5 Issue 10 Pg. 1706-1711 (10 2017) ISSN: 2050-0904 [Print] England
PMID29026577 (Publication Type: Case Reports)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: